Pfizer's vaccine is over 90 percent effective against symptomatic COVID-19 in kids
Pfizer's vaccine was found to be more than 90 percent effective against symptomatic COVID-19 in children between the ages of 5 and 11, the company says.
Pfizer and BioNTech released the new data on Friday from a trial that included about 2,000 children after previously seeking FDA emergency authorization to administer its COVID-19 vaccine to kids, CNN reports. The company said the vaccine was shown to be safe and 90.7 percent effective against symptomatic COVID-19 in children aged 5 to 11. The Pfizer vaccine is fully approved for those 16 and older and has also been authorized for those between 12 and 15.
Previously, Pfizer said its vaccine was found to be "safe, well-tolerated, and showed robust neutralizing antibody responses" in children 5 to 11 in a trial. FDA advisers are set to meet next week to consider whether to recommend authorizing the vaccine for younger kids, according to The New York Times.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The White House has said this vaccine could potentially be available for kids by Thanksgiving, and it unveiled a plan to distribute the vaccine after its approval earlier this week. Policy adviser Sonya Bernstein told The New York Times the Biden administration is aiming for a "kid-friendly experience that makes sure that we're getting shots in arms with trusted providers in ways that makes parents feel comfortable."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
The Spanish cop, 20 million euros and 13 tonnes of cocaine
In the Spotlight Óscar Sánchez Gil, Chief Inspector of Spain's Economic and Tax Crimes Unit, has been arrested for drug trafficking
By The Week UK Published
-
5 hilarious cartoons about the rise and fall of Matt Gaetz
Cartoons Artists take on age brackets, backbiting, and more
By The Week US Published
-
The future of X
Talking Point Trump's ascendancy is reviving the platform's coffers, whether or not a merger is on the cards
By The Week UK Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
WHO declares mpox a global health emergency
Speed Read An outbreak of the viral disease formerly known as monkeypox continues to spread in Africa
By Rafi Schwartz, The Week US Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published